Your browser doesn't support javascript.
loading
Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Bride, Karen L; Vincent, Tiffaney; Smith-Whitley, Kim; Lambert, Michele P; Bleesing, Jack J; Seif, Alix E; Manno, Catherine S; Casper, James; Grupp, Stephan A; Teachey, David T.
Afiliação
  • Bride KL; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;
  • Vincent T; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;
  • Smith-Whitley K; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA;
  • Lambert MP; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA;
  • Bleesing JJ; Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH;
  • Seif AE; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;
  • Manno CS; Department of Pediatrics, New York University Langone Medical Center, New York, NY; and.
  • Casper J; Division of Pediatric Hematology, Oncology and Bone Marrow Transplant, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI.
  • Grupp SA; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;
  • Teachey DT; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;
Blood ; 127(1): 17-28, 2016 Jan 07.
Article em En | MEDLINE | ID: mdl-26504182
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Sirolimo / Doenças Hematológicas / Imunossupressores / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Sirolimo / Doenças Hematológicas / Imunossupressores / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article País de publicação: Estados Unidos